131 related articles for article (PubMed ID: 11277521)
21. Design, synthesis, and biological evaluation of aryloxyethyl thiocyanate derivatives against Trypanosoma cruzi.
Elhalem E; Bailey BN; Docampo R; Ujváry I; Szajnman SH; Rodriguez JB
J Med Chem; 2002 Aug; 45(18):3984-99. PubMed ID: 12190320
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological characterization of new aryloxyindole-4,9-diones as potent trypanosomicidal agents.
Tapia RA; Salas CO; Vázquez K; Espinosa-Bustos C; Soto-Delgado J; Varela J; Birriel E; Cerecetto H; González M; Paulino M
Bioorg Med Chem Lett; 2014 Aug; 24(16):3919-22. PubMed ID: 25008454
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinone derivatives against different Trypanosoma cruzi discrete type units: Identification of a promising hit compound.
Lara LS; Moreira CS; Calvet CM; Lechuga GC; Souza RS; Bourguignon SC; Ferreira VF; Rocha D; Pereira MCS
Eur J Med Chem; 2018 Jan; 144():572-581. PubMed ID: 29289882
[TBL] [Abstract][Full Text] [Related]
24. Differential in vitro activity of the DNA topoisomerase inhibitor idarubicin against Trypanosoma rangeli and Trypanosoma cruzi.
Jobe M; Anwuzia-Iwegbu C; Banful A; Bosier E; Iqbal M; Jones K; Lecutier SJ; Lepper K; Redmond M; Ross-Parker A; Ward E; Wernham P; Whidden EM; Tyler KM; Steverding D
Mem Inst Oswaldo Cruz; 2012 Nov; 107(7):946-50. PubMed ID: 23147154
[TBL] [Abstract][Full Text] [Related]
25. Structure-activity relationship of new growth inhibitors of Trypanosoma cruzi.
Cinque GM; Szajnman SH; Zhong L; Docampo R; Schvartzapel AJ; Rodriguez JB; Gros EG
J Med Chem; 1998 Apr; 41(9):1540-54. PubMed ID: 9554887
[TBL] [Abstract][Full Text] [Related]
26. Quinoxaline N,N'-dioxide derivatives and related compounds as growth inhibitors of Trypanosoma cruzi. Structure-activity relationships.
Aguirre G; Cerecetto H; Di Maio R; González M; Alfaro ME; Jaso A; Zarranz B; Ortega MA; Aldana I; Monge-Vega A
Bioorg Med Chem Lett; 2004 Jul; 14(14):3835-9. PubMed ID: 15203172
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and tripanocidal activity of ferrocenyl and benzyl diamines against Trypanosoma brucei and Trypanosoma cruzi.
Velásquez AM; Francisco AI; Kohatsu AA; Silva FA; Rodrigues DF; Teixeira RG; Chiari BG; de Almeida MG; Isaac VL; Vargas MD; Cicarelli RM
Bioorg Med Chem Lett; 2014 Apr; 24(7):1707-10. PubMed ID: 24630563
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, physicochemical properties of allopurinol derivatives and their biological activity against Trypanosoma cruzi.
Raviolo MA; Solana ME; Novoa MM; Gualdesi MS; Alba-Soto CD; Briñón MC
Eur J Med Chem; 2013 Nov; 69():455-64. PubMed ID: 24090917
[TBL] [Abstract][Full Text] [Related]
29. Dehydrodieugenol B derivatives as antiparasitic agents: Synthesis and biological activity against Trypanosoma cruzi.
Ferreira DD; Sousa FS; Costa-Silva TA; Reimão JQ; Torrecilhas AC; Johns DM; Sear CE; Honorio KM; Lago JHG; Anderson EA; Tempone AG
Eur J Med Chem; 2019 Aug; 176():162-174. PubMed ID: 31103897
[TBL] [Abstract][Full Text] [Related]
30. Design and synthesis of aryloxyethyl thiocyanate derivatives as potent inhibitors of Trypanosoma cruzi proliferation.
Szajnman SH; Yan W; Bailey BN; Docampo R; Elhalem E; Rodriguez JB
J Med Chem; 2000 May; 43(9):1826-40. PubMed ID: 10794699
[TBL] [Abstract][Full Text] [Related]
31. Bisphosphonates inhibit the growth of Trypanosoma brucei, Trypanosoma cruzi, Leishmania donovani, Toxoplasma gondii, and Plasmodium falciparum: a potential route to chemotherapy.
Martin MB; Grimley JS; Lewis JC; Heath HT; Bailey BN; Kendrick H; Yardley V; Caldera A; Lira R; Urbina JA; Moreno SN; Docampo R; Croft SL; Oldfield E
J Med Chem; 2001 Mar; 44(6):909-16. PubMed ID: 11300872
[TBL] [Abstract][Full Text] [Related]
32. Potent second generation vinyl sulfonamide inhibitors of the trypanosomal cysteine protease cruzain.
Roush WR; Cheng J; Knapp-Reed B; Alvarez-Hernandez A; McKerrow JH; Hansell E; Engel JC
Bioorg Med Chem Lett; 2001 Oct; 11(20):2759-62. PubMed ID: 11591518
[TBL] [Abstract][Full Text] [Related]
33. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
[TBL] [Abstract][Full Text] [Related]
34. In Vitro and In Vivo Investigation of the Inhibition of Trypanosoma brucei Cell Growth by Lipophilic Bisphosphonates.
Yang G; Zhu W; Kim K; Byun SY; Choi G; Wang K; Cha JS; Cho HS; Oldfield E; No JH
Antimicrob Agents Chemother; 2015 Dec; 59(12):7530-9. PubMed ID: 26392508
[TBL] [Abstract][Full Text] [Related]
35. New oxirane derivatives of 1,4-naphthoquinones and their evaluation against T. cruzi epimastigote forms.
Carneiro PF; do Nascimento SB; Pinto AV; Pinto Mdo C; Lechuga GC; Santos DO; dos Santos Júnior HM; Resende JA; Bourguignon SC; Ferreira VF
Bioorg Med Chem; 2012 Aug; 20(16):4995-5000. PubMed ID: 22795899
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, Biological Evaluation and Molecular Docking of New Benzenesulfonylhydrazone as Potential anti-Trypanosoma cruzi Agents.
Elizondo-Jimenez S; Moreno-Herrera A; Reyes-Olivares R; Dorantes-Gonzalez E; Nogueda-Torres B; Oliveira EAG; Romeiro NC; Lima LM; Palos I; Rivera G
Med Chem; 2017; 13(2):149-158. PubMed ID: 27396731
[TBL] [Abstract][Full Text] [Related]
37. Leishmanicidal and trypanocidal activities of 2-aminocyclohexanol and 1,2-cyclohexanediamine derivatives.
Rebollo O; del Olmo E; Ruiz G; López-Pérez JL; Giménez A; San Feliciano A
Bioorg Med Chem Lett; 2008 Jan; 18(1):184-7. PubMed ID: 18024033
[TBL] [Abstract][Full Text] [Related]
38. Repositioning FDA Drugs as Potential Cruzain Inhibitors from Trypanosoma cruzi: Virtual Screening, In Vitro and In Vivo Studies.
Palos I; Lara-Ramirez EE; Lopez-Cedillo JC; Garcia-Perez C; Kashif M; Bocanegra-Garcia V; Nogueda-Torres B; Rivera G
Molecules; 2017 Jun; 22(6):. PubMed ID: 28629155
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of novel quinine analogs and evaluation of their effects on Trypanosoma cruzi.
Ceole LF; Gandhi H; Villamizar LH; Soares MJ; O'Sullivan TP
Future Med Chem; 2018 Feb; 10(4):391-408. PubMed ID: 29380636
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and 2D-QSAR studies of neolignan-based diaryl-tetrahydrofuran and -furan analogues with remarkable activity against Trypanosoma cruzi and assessment of the trypanothione reductase activity.
Hartmann AP; de Carvalho MR; Bernardes LSC; Moraes MH; de Melo EB; Lopes CD; Steindel M; da Silva JS; Carvalho I
Eur J Med Chem; 2017 Nov; 140():187-199. PubMed ID: 28926763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
